Summary Rats bearing a transplanted nickel-induced rhabdomyosarcoma (RMS 9-4/0), treated with chlorozotocin (CZT), an alkylating agent, showed an amplified metastatic invasion of the lung (median of 165 lung tumour nodules, compared to 3 for untreated controls). A higher level of metastatic invasion (200 nodules) was reached spontaneously after the grafting of the S4T line, which was obtained by successive in vivo passages of RMS 9-4/0 cells in CZT treated rats. S4T tumour cells also invaded the liver and a considerable proportion of the lymph nodes. The NT4T line, obtained by successive in vivo passages in untreated rats, showed a lesser degree of enhancement of metastatic capacity (57 nodules). Both derived lines proved to be more aggressive than the parental, proliferated more rapidly, and were resistant to CZT toxicity. Only the non-treated lineage became more resistant to NK lysis. The S4T line lost its myogenic differentiation and was best described as a fibrohistiosarcoma, whereas NT4T did not. Chromosome analysis demonstrated a reduced range of chromosome number per cell in both lines. We conclude that both S4T and NT4T tumours became more metastatic than RMS 9-4/0 as the result of tumour progression through in vivo passages, and that in addition S4T acquired a spontaneously higher metastatic potential, similar to that which occurred in rats grafted with RMS 9-4/0 or NT4T tumours and treated by CZT. This suggests an inheritable mutation in the S4T line.
A major problem of cancer therapy is the emergence of tumour subpopulations resistant to the treatment. The probability that a tumour will generate resistant variants could be related to genetic instability (Goldie & Coldman, 1984; Stephens et al., 1986) . According to Cifone and Fidler (1981) , genetic instability is also an important characteristic of metastatic cell lines. Therapy would, therefore, possibly select subpopulations that are potentially the most metastatic in the tumour. On the other hand, previous studies suggested that chemotherapy, since it uses potentially mutagenic agents, could be responsible for tumour progression towards a more malignant phenotype (Kerbel & Davies, 1982) . Repair mechanisms may allow mutated cells to survive, and increase both tumour drug resistance and phenotypic heterogeneity.
We have described the enhancing effect of a nitrosourea, chlorozotocin 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose (CZT), on the metastatic ability of RMS 9-4/0, a rat rhabdomyosarcoma (Poupon et al., 1984) . We hypothesized that this action was due to the emergence of a subpopulation of the RMS 9-4/0 tumour, that was both resistant to CZT and highly metastatic. We failed to obtain a selection for CZT resistance in the primary tumour because the treated rats were rapidly killed by the growth of lung metastases. To overcome this, the treated primary tumour cells were injected into new recipients that were also treated and this cycle was repeated until a fully resistant population was obtained. The metastatic ability of these cells was then studied.
Materials and methods

Animals
Ten to 12 week old female Wistar AG (WAG) rats, bred at the Institut de Recherches Scientifiques sur le Cancer and maintained in pathogen-limited conditions, were used. Tumours RMS 9-4/0 is a rhabdomyosarcoma induced in our laboratory by an i.m. injection of 20mg of colloidal nickel (Prolabo, France) into the thigh of a WAG rat (Sweeney et al., 1982) . When it reached 20mm in diameter, the tumour was removed and dissociated in a 0.25% trypsin solution. The cells were plated and maintained as a continuous line in Dulbecco's modified Eagle's medium (DMEM) (Grand Island Biological Co., Grand Island, NY) supplemented with 10% heat-inactivated foetal calf serum (Flow Laboratories, UK) and an antibiotic solution of streptomycin-penicillin (10 jg ml-1). Cells were detached by trypsinization from subconfluent cultures. A suspension of I05 cells in 0.1 ml of medium was injected s.c. into the flanks of syngeneic rats midway between the inguinal and axillary areas.
A group of the tumour-bearing rats were not drug-treated and gave rise to the NT(x)T tumour lineage, where (x) designates the number of cycles performed. When rats were moribund the tumour was excised, finely minced with a scalpel, and then allowed to grow in the complete medium described above. At confluence, cells were injected s.c. into new animals. Part of the cells were frozen for further analyses.
Other tumour-bearing rats were treated weekly with i.p. injections (10mgkg-1) of chlorozotocin (diluted in PBS, kept frozen at -200C, and thawed immediately before injection). The tumour lineage thus established was named S(x)T and was passed into new animals as described above.
In the NT(x)T group, some of the rats were also treated with CZT, similarly to the S(x)T group, as a control of CZT efficiency.
In the S(x)T group, some of the rats were not treated in order to assess the evolution of spontaneous metastatic ability in the S(x)T lineage ( Figure 1) After a 5 h incubation at 37°C in a 5% Co2 atmosphere, 0.1 ml of supernatant was harvested from each well and the radioactivity was monitored in an LKB gamma counter. The percent lysis was calculated from the formula 100 x (E-S)/ (T-S) where E = cpm released in the wells containing effector and target cells; S = cpm released in the wells containing target cells and medium alone (spontaneous release); and T = cpm released in the wells containing target cells and 1 N hydrochloric acid solution (maximum lysis). Three experiments were performed that gave similar results. Each experiment gave identical relationships for a given cell line, although there were differences in the actual values obtained. Figure 5 shows the results of one experiment. Regression analysis was performed and computed values used for the discussion.
Results
In vivo behaviour of the tumour cell lines 9-4/0 parental cell line When injected into WAG rats, 9-4/0 tumour cells killed their hosts in about 86 days (Table I) , when the tumour's mean diameter (MD) reached -40mm (37+1mm). The median number of lung metastases (LM) was 3 (range 0-26) and only a few, mainly peripheral, lymph nodes (LN) were invaded. CZT treatment had an evident inhibitory effect on tumour growth rate, the MD of CZTtreated rat tumours being 15 +1 vs. 23 + 2 mm for controls on day 55, (P<0.01) (Figure 2 ), but the rat survival time was shortened (56 + 2 days). This reduced life span was due to the dramatic enhancement of the LM number (median of 165, range 32-181, P<0.01). CZT treatment had no effect on LN invasion.
NT(x) T lineage A progressive enhancement of the NT(x)T lineage's metastatic abilities through in vivo passages was observed, both in the lungs (for NT4T, the median LM was Ten tumour-bearing rats from groups that have been treated identically were examined at autopsy for their metastatic invasion. Autopsy was performed when rats were moribund. One S4T tumour-bearing rat died several days before the remainder of the group, and was not included in the analysis. Frequency of lymph node invasion was assessed at different sites. When the frequency reached more than 50%, the mean diameter of the lymph node metastases is indicated. aMean diameter expressed in mm+s.d.; bThe mediastinal lymphatic tissue invasion was semi-quantitatively evaluated on a scale from -, equivalent to the absence of invasion, to 5+, corresponding to the maximum; Clndicates invasion of the contralateral lymph nodes. P: statistical difference between treated and non-treated tumours, analysed by Student's t test.
The S(x)T lineage tumours grew more rapidly than the NT(x)T tumours (MD 41+1mm vs. 32+1mm on day 32, P<0.01), were only slightly sensitive to the inhibitory effect of CZT (MD 37+1 mm vs. 41 +1 mm, P<0.05), and became less sensitive to the CZT enhancing effect on their metastatic ability (median LM 191, range 23-TMTC, P>0.05) as the selection proceeded. Whether CZT-treated or not, these tumours killed their hosts three times more rapidly than the nontreated 9-4/0 tumour (survival time 32+3 days vs. 86+5 days, P < 0.01).
In vitro, the S4T cell line also behaved differently from the parental cell line. Whereas NT4T and 9-4/0 cells grew in dense areas and reached confluence in petri dishes, S4T cells remained isolated from one another, and when the density of cells caused them to touch, the newly born cells detached from the dishes ( Figure 3B ). In soft agar, S4T cells did not form spheroid aggregates, but migrated into the gel ( Figure  3C ).
Chromosome analysis 9-4/0 rhabdomyosarcoma is very heterogeneous in terms of chromosome content. In vitro cultured 9-4/0 cells presented a wide range of chromosome number/cell, from 30 to 130, so that no mode could he identified. NK lysis assay 9-4/0 tumour cells showed a weak sensitivity to NK cytotoxicity (24.5% of lysis at the effector: target ratio of 100:1). There was no significant change in sensitivity throughout NT(x)T lineage evolution until NT4T shifted towards resistance (13.0% lysis at 100:1). SIT cells were much more NK sensitive than the NT(x)T lineage and 9-4/0 tumour cells (34.7% lysis at 100:1). S2T, S3T and S4T cell sensitivities were similar to those of the parental cells (respectively, 28.0, 22.3 and 25.4% lysis at 100:1) ( Figure 5 ).
Discussion
The alkylating agent CZT, a widely used antitumoral drug, has a paradoxical effect on the rat RMS 9-4/0 tumour development. Thus, whilst it slows the primary tumour growth rate, it also enhances the metastatic invasion of the lungs (Pauwels et al., 1985) . We established that this effect was due to a direct effect of CZT on the tumour cells, rather than on the host, as treatment of the rats prior to the injection of RMS 9-4/0 did not give the same results (Poupon et al., 1984) . We suspected a CZT-resistant subpopulation of the tumour to be highly metastatic, associating genetic instability and metastatic ability (Cifone & Fidler, 1981) and the postulated relationship between genetic instability and progression to a more drug-resistant phenotype by means of the generation and selection of variants (Goldie & Coldman, 1984; Stephens et al., 1986) .
However, when injected into new recipient rats, the in vivo treated tumour cells were found not to have acquired a higher metastatic efficiency. In fact, after the drug selection procedure, the tumour attained a new equilibrium in terms of drug resistance and metastatic ability amongst other characteristics. CZT treatment was not sufficient to produce a fully resistant tumour at the first passage. The purpose of the experiments described in the present study was to select a resistant cell population, by means of successive passages and in vivo CZT treatments of RMS 9-4/0 cells, the control Figure 3A ).
S(x)T lineage The S(x)T tumours rapidly became more aggressive and invasive. As early as the second in vivo passage (S2T), the tumour invaded all the inguinal, axillary, lumbaraortic and mediastinal LN and frequently invaded the mesenteric LN. It metastasized to the liver in 20% of the rats, in a diffuse manner, whereas LM were always well delimited nodules. The number of LM in non-treated S(x)T tumour-bearing rats grew rapidly to reach the number of LM in CZT treated 9-4/0 tumour-bearing rats by the fourth in vivo passage (S4T: median LM 200, range 146-TMTC). These changes in the metastatic behaviour of the 9-4/0 rhabdomyosarcoma were concomitant with a modification in the histological aspect of the tumour. Microscopic examination of S3T tumoral tissue revealed fibroblastic or histiocytic-like cells with irregular nuclei. These cells were arranged in a storiform or occasionally fascicular manner.
We also observed polynucleated giant cells, foam cells, and abundant collagen. Mitogenic activity was elevated ( Figure  3A ). All these features suggested that S3T tumour had become a pleiomorphic histiocytoma. The NT(x)T control lineage demonstrated a marked progression towards a more aggressive behaviour. We observed an accelerated growth rate, an increased invasive ability, and interestingly, an increased resistance to CZT, despite the fact that the cells had not been previously in contact with the drug.
The possibility that successive in vivo passages of tumour cells select the most aggressive subpopulations of the parental tumour has been suggested by the report that enhanced metastatic ability occurred after the repeated passage of either metastases (Talmadge & Fidler, 1982) or the primary tumour (Vaage, 1980) . Among the tumour cells subcutaneously injected into the animal, those which are the most able to resist host defenses, to attach to, and invade, the surrounding tissue, and which proliferate the most rapidly, would probably overpopulate the whole tumour.
Metastatic subpopulations obviously possess all these properties, and could be selected in this way. Nowell (1976) proposed (Greaves & Faccini, 1981) . Although the histogenesis of fibrohistiocytic tumours is not yet completely defined, it seems highly unlikely that they are closely related to rhabdomyosarcomas. We ascribe this striking change of S(x)T lineage behaviour to a treatment-induced genetic alteration. This is supported by the fact that alkylating agents demonstrate mutagenic properties (Bradley et al., 1980; Franza et al., 1980) . The modified histology of S(x)T lineage tumours correlates with several of our experimental findings. Previous studies (Hart, 1982; Nicolson & Custead, 1982; Tarin & Price, 1981; Tarin et al., 1984) tended to show that it is impossible to adapt metastatic cells to new target organs, but the capacity to disseminate to the liver, as acquired by late S(x)T passages, is inherent to fibrohistiocytic tumours. Sensitivity to NK cell lysis may be related to the tumour cell stage of differentiation (Werkmeister et al., 1982 However, the histologic divergence of the S(x)T lineage could explain neither the enhancement of metastatic capacity of RMS 9-4/0 tumours in rats treated with CZT, nor why this effect was not observed when the S4T tumour was treated by CZT. Previous results (Pauwels et al., 1985 (Pauwels et al., ,1986 suggest that alkylating agents might act as inducers of proliferation of RMS 9-4/0 and 9-4/0-derived tumour cells.
Quiescent disseminated cells may, therefore, have given rise to metastases when treated. This characteristic induced by CZT could have become permanent in S4T cells, thus masking any enhancement of their metastatic behaviour after treatment.
Metastases are known to frequently resist therapy, but only a few reports have described an enhancement of tumour dissemination subsequent to chemotherapy. Various authors (Van Putten et al., 1975; Steel & Adams, 1977) showed that cyclophosphamide pre-treatment could increase, by more than 1000-lold, the number of lung colonics in a mouse mammary tumour model. This effect was related to drug cytotoxicity against host tissue . Lazo et al. (1978) found an enhancement of lung colonies after in vitro treatment of B16 melanoma cells with ICRF-159, an agent known to reduce in vivo metastatic formation, and concluded that the drug had a specific effect on the tumour cells. More recently, McMillan et al. (1986) reported a greater than 10-fold increase in the lung colonizing abilities of B16 melanoma sublines treated in vitro with hydroxyurea (HU) and allowed to recover 24h before injection. They related this effect to the mutagenic properties of HU which lead to gene amplification. In all of these experiments, i.v. injection of tumour cells was chosen as the metastatic model. This procedure reproduces the final steps of the metastatic process, that seem to be implicated in the therapy-induced enhancement of tumour dissemination. Our model of spontaneous metastasis includes the necessity for the tumour cells to escape from the primary tumour and enter the vascular system. This could for example involve the motility and the degradative abilities of the tumour cells, as evidenced by our studies of S4T cells in vitro (unpublished results) . Finally, our work highlights the danger of in vivo treatment of well-established tumours with potentially mutagenic chemotherapeutic agents, a problem to which Kerbel and Davies have drawn cancerologists' attention since 1982.
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